1st ProCAncer-I Project Dissemination Event in Vienna
We are really happy to announce that we will be present at the ECR Congress in Vienna on 13 - 17 of July 2022. During the congress, a special Session will take place on the 15th of July, presenting and discussing on the ProCAncer-I project with the title: Building...
Data sharing for a good cause – How the Data Governance Act (DGA) will help ProCAncer- I
The European Union is actively working on improving the digital environment for the benefit of all Europeans. Professor Tsiknakis took part in a recent feature in the EU Council site on how the EU protects users online, ensures cybersecurity and facilitates the...
Use Cases mapped along the prostate cancer management continuum
Nowadays, prostate cancer is highly curable if detected in its early stages. Indeed, when organ-confined at diagnosis, the five-year survival rate of prostate cancer is close to 100%. Unfortunately, current prostate cancer diagnostic pipeline has several limitations. Prostate specific antigen (PSA) has a low sensitivity and specificity.
Introducing FUTURE-AI: Best practices for trustworthy AI in medical imaging
ProCAncer -I Project is part of the five H2020 projects that share the same vision, principles and challenges. These projects are funded under the same Action Line: AI for Health Imaging (Call: H2020-SC1-FA-DTS-2019-1): CHAIMELEON (chaimeleon.eu), EuCanImage...
Our 3rd issue of the ProCAncer-I newsletter has been published!
Our third Summer Newsletter has been released! Read more here: 3nd Winter Newsleter Do not forget to subscribe for our next editions!
Our 2nd issue of the ProCAncer-I newsletter has been published!
Our second winter Newsletter has been released! Read more here: 2nd Winter Newsleter Do not forget to subscribe for our next editions!
System for detection of tumors based on magnetic resonance: prostate analysis (video)
How could AI improve prostate cancer diagnosis? This video from the research group of prof. Daniele Regge (coordinator of the clinical activities) explains AI application to prostate MRI.
Anonymous? Estimating the Risk of Re-identification Within the ProCAncer-I Health Data Sets
by Emily Johnson and Theresa Henne Age Weight PSA value Gleason Group 33 112,2 kg 7,9 ng/ml 3+4 Table 1. Is this data anonymous? Data sample of a fictional prostate cancer patient Imagine you stumble across the information given above - it may be part of...
Best Student Paper Award in the 21st IEEE International Conference on BioInformatics and BioEngineering
Our researchers received the Best Student Paper Award in Bioengineering category in the 21st IEEE International Conference on BioInformatics and BioEngineering that was held on October 25-27, 2021, at Kragujevac (Serbia). The award-winning paper is entitled: "A Deep...
Artificial Intelligence: a new age of radiology?
On Monday the 25th of October 2021, our researchers participated in the virtual meeting on "Artificial Intelligence: a new age of radiology?" organized by University of Torino with prof. Daniele Regge as Chairman. Aim of the Residents’ radiology online meeting- II...
Multiparametric MRI of the prostate for PI-RADS Classification and the ProCancer-I project
Α lecture about Multiparametric MRI of the prostate for PI-RADS and the ProCancer-I project was held on line and presented by Sherif Mohsen Shalaby. The lecture was οrganized by Prof. Neri and Prof. Dania Cioni, for the radioplogists and residents of the University of...
ProCAncer-I in «Big data and artificial intelligence in cancer imaging»
The workshop «Big data and artificial intelligence in cancer imaging», organized during IEEE BHI - BSN 2021 was held on the 27th of July 2021. Prof Tsiknakis, as Coordinator of ProCAncer- I (www.procancer-i.eu) presented the vision, principles and challenges of the...
